Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib-Reference-Cited by-同舟云学术

Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib

Published:2020-02-07 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Dalle Fratte Chiara,Guardascione Michela,De Mattia Elena,Borsatti Eugenio,Boschetto Roberta,Farruggio Angelo,Canzonieri Vincenzo,Romanato Loredana,Borsatti Rachele,Gagno Sara,Marangon Elena,Polano Maurizio,Buonadonna Angela,Toffoli Giuseppe,Cecchin Erika

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference38 articles.

1. A novel dic (17;18) (p13.1;q11.2) with loss of TP53 and BCR/ABL rearrangement in an Imatinib resistant chronic myeloid leukemia;Al-achkar;Mol. Cytogenet.,2012

2. Genetic modifiers of the p53 pathway;Basu;Cold Spring Harb. Perspect. Med.,2016

3. Molecular subtypes of KIT/PDGFRA wild-type gastrointestinal stromal tumors;Boikos;JAMA Oncol.,2016

4. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data;Bouaoun;Hum. Mutat.,2016

5. Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting;Bouchet;Eur. J. Cancer,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot Study by Liquid Biopsy in Gastrointestinal Stromal Tumors: Analysis of PDGFRA D842V Mutation and Hypermethylation of SEPT9 Presence by Digital Droplet PCR;International Journal of Molecular Sciences;2024-06-20

2. Existing status and future advancements of adulteration detection techniques in herbal products;Molecular Biology Reports;2024-01-18

3. Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation;Pharmacogenomics;2023-12

4. Rare gene mutations of wild-type gastrointestinal stromal tumors;2023-01-12

5. Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?;Biomedicines;2021-09-26